FDA

These are recommendations for travel of the highest, fourth level, according to which it is not recommended at all, CdM reports.
"Do not travel to Montenegro due to COVID-19. Read the State Department's page on coronavirus before planning any international trip," reads the announcement, which was also published on the website of the United States Embassy in Montenegro.

Broadway theatergoers will need to prove they've been vaccinated for COVID-19 and masks will be required when theaters reopen in the coming weeks, producers announced on July 30.

class='cf'>

Over the past month, Israel, the world's most heavily vaccinated country (with leading mRNA jabs, no less) has seen the number of positive COVID tests has risen by more than 30x as the number of active infections in the country has surpassed 10,000.

The new chapter of the "Freedom" campaign will be implemented from tomorrow for the voluntary vaccination of adolescents aged 15-17, after the necessary consent of the parents.

BC Partners announced the sale of the majority stake in Pharmathen to the international private equity firm Partners Group. The transaction values ​​the company at 1.6 billion euros.

Pharmathen was founded in 1969 and was acquired by BC Partners in 2015 for 475 million euros and is now the leading European company in the field of drug administration technology, the announcement said.

Pfizer is preparing a third booster Covid shot to take on the deadly Delta variant, the company revealed.

The pharma corporation is seeking emergency authorization from the US FDA for another jab to be administered six-to-twelve months after full vaccination.

The information was revealed by former FDA Commissioner Scott Gottlieb

US FDA expanded the emergency use authorization for Pfizer's Covid-19 vaccine including people ages 12 to 15.

Coordinator of Romania's COVID-19 vaccination campaign Valeriu Gheorghita said on Tuesday that there is a clear prospect of immunising this summer 12-15-year-olds in the country using the Pfizer BioNTech vaccine.

BioNTech-Pfizer said Wednesday their vaccine showed 100 percent efficacy against the coronavirus in 12 to 15 year olds, as they eye approval for adolescents to get the jabs before the next school year.

Phase 3 trials carried out on 2,260 adolescents in the United States "demonstrated 100 percent efficacy and robust antibody responses", the companies said in a statement.